The cardinal issues in this study are vision, mission, failing and menace. The three companies Pfizer, Novartis and GlaxoSmithKline who are the top 10 planetary drug company are being compared to analyze the cardinal issues. The three companies are traveling towards the same vision and mission. They face the same menace. However, there are differences in their failings. Their vision is to be the most sure company in the pharmaceutical industry and their mission is to develop an advanced and choice drug. Patent termination and competition from generic drugs are their menace in the industry. Pfizer has the failings of intrenchment in low growing curative market and limited incursion of high growing oncology market whereas the failing of GlaxoSmithKline is its restructuring programme incurs higher disbursals. Last, the failings of Novartis are deficiency of resources to catch attractive chance and merely one preparation is available.

We analyse the distant environment of planetary pharmaceutical industry by utilizing PEST analysis while Michael E. Porter ‘s 5 forces is used to analyze the industry environment. Besides, vision and mission, long-run aims, short-run aims, corporate societal duties and internal environment is analysed by comparing 3 of the top 10 companies. SWOT analysis is used to analyze and compare the internal environment of the 3 companies. The inside informations are discussed in the contents below.

Political factors include the regulations and ordinances set by the authorities. It brings big influence to the industry as the patent protection had been set for 20 old ages merely but an experimental drug takes 10-15 old ages to go from the lab to the patient. The patent is about expired when it reaches to the market. So, it gives a opportunity for the development of generic drugs which have same ingredients with the original branded but have 60 % lower monetary value. In add-on, authorities is the lone one powerful buyer in the pharmaceutical industry. So there is authorities monetary value control in this industry. The pharmaceutics must sell the drugs at the monetary value that had been set.

Buying power of clients and the company ‘s cost will be affected by economic factors like planetary economic crisis, rising prices rates and exchange rates. The planetary economic crisis will do the peoples unwilling to pass on the health care and it consequences in the increased force per unit area in pricing for pharmaceutics. Besides, the force per unit area from the stockholders would increase and it could do more amalgamations and acquisitions in the industry.

Problem of fleshiness is increasing presently and it is a wellness hazard for human. Besides, there is Alzheimer ‘s disease in the society. The pharmaceutical companies have new thought to develop drugs for Alzheimer ‘s disease. This had been informed to the consumers and they have high outlook for this intervention. Hence, client service of pharmaceutical industry may hold more force per unit area and their instruction degree may necessitate to be addition.

Advance engineering is use in pharmaceutical industry. New concern chance in new therapy systems and service commissariats could be created through the technological promotions. The growing in new information and communications engineerings, societal media, customised interventions and direct to patient advertisement would convey some impacts to the industry such as can pass on straight with patient and consumers will necessitate more antiphonal service installations.

The barrier of entrant in pharmaceutical industry is really high due to lead clip for a new drug, high research and development ( R & A ; D ) cost every bit good as clinical proving cost. There are besides many regulations and ordinances set by authorities that the new company demand to follow. Besides, the lead clip to market an mandate drug could be taking 10-15 old ages. Furthermore, expertness from the field of life science and pharmaceutical is required and a batch of progress engineering is needed to bring forth a high quality drug.

Customers would hold high bargaining power because of the generic drugs are available in markets while there is low dickering power for the prescription drugs. Generic drugs have same ingredient with the original trade name but launched at less than 60 % of the monetary value.

Suppliers have really low dickering power as the cost of a drug ‘s ingredients is really really low per centum from the entire costs to bring forth it. So, it is hard for them to increase their monetary value to bear down to pharmaceutical industry. Furthermore, planetary sourcing had caused a farther decrease in the cost of natural stuff. So, most of the pharmaceutical companies start to trust on the in-licensing for their new merchandises. Hence, China and India is the cardinal outsourcing locations for cheaper ingredients.

Pfizer has a major rival, Glaxo. Glaxo had a blockbuster drug-Zantac which is for tummy ulcers. Hence, Glaxo went from being a bantam participant to a top grade planetary company due to the strength of Zantac.

Amalgamations and acquisitions would be expected to response to decelerating gross, worsening productiveness and hard currency rich company but borders is worsening. This is because it could take to planetary gross revenues and selling, economic systems of graduated table every bit good as more efficient research and development attempts. As a consequence, Numberss of rivals will cut down. Therefore, amalgamations and acquisitions company will has consolidated at the planetary degree. In the instance, Merck was merged with Schering-Plough in March 2009. Besides, amalgamations besides resulted in the formation of Sanofi-Aventis, Novartis, GlaxoSmithKline and AstraZeneca, while Pfizer had acquired Monsanto ( Warner-Lambert ) . Pfizer was given full selling rights to Lipitor ( universe ‘s best selling drug ) through the acquisition of Warner-Lambert.

Menace of replacements is high as challengers could establish generic drugs at a lower monetary value one time the patent of original trade names had expired, and the lead clip would be reduced to 18 months. The assurance of clients towards the drugs had heightening in utilizing of alternate redresss. Hence, the growing of generic drugs is increasing old ages by old ages. For illustration, Viagra is the trade name name drug of Pfizer while there is a utility drug and the generic name is Sildenafil.

All the 3 companies are traveling towards the same mission which is to develop advanced medical specialties. They want to develop advanced & A ; quality medical specialties to bring around diseases so that people feel better, unrecorded thirster and remain happier.

All the 3 companies are traveling towards the same vision which is to be a sure and valued pharmaceutical company. GSK want nothing waste to landfill by 2020. For Novartis, they want to increase the degree of disease consciousness of the populace by making community wellness instruction. Their vision will be seen by the populace as a sure company.

SWOT analysis is used to analyze the internal strengths and failings of a company and external chances and menaces that confronting by the company. It helps the director to supply a speedy overview about the strategic of the company.

Three of them have strong diversified portfolio on medical specialties, which are fast turning merchandises in the market, particularly in supplying pharmaceutical merchandises, vaccinums and consumer health care merchandises. Besides, they besides actively involved in the research and development ( R & A ; D ) of new drugs like mark a individual molecule for a peculiar disease. The intent of develop a new drug is to happen out the most valuable and new medical solutions. Capital, human resources, and engineering expertness are required in R & A ; D of new drugs.

Pfizer is entrenched in low growing cardiovascular ( CV ) and cardinal nervous system ( CNS ) market. These markets are forecasted to execute ill due to exposure to generic rivals. It should perforate more in high growing oncology market.

For GSK, it intends to cut down its complexness and better operation efficiency by enforced restructuring plan. This plan requires the alterations from company construction and operation which may ensue in high outgos and it will adversely impact the fiscal consequence.

Novartis is confronting the job of deficiency of resources to seek more outstanding chances in the market. The resources include the investing capital, human resource, and engineering expertness. As a consequence, Novartis has to cut down its intervention spread in certain countries like rural countries, which are far from urban countries since Novartis has limited resources to develop new drugs.

Three of them have similarity in look intoing the new drugs on peculiar diseases that are non good controlled by current drugs. This provides an chance to the patients with rare diseases to entree those advanced new drugs. They besides intend to diversify their concerns through planetary amalgamations and acquisitions and therefore it will cut down the figure of rivals and increase gross and market portion. Amalgamations and acquisitions enable the houses to entree into new market sections. They could seek out more new invention chances since there is cut downing of rivals in the market.

The above 3 companies are holding the same menaces which are patent termination, competition from generic drug and monetary value control. The challengers will establish the generic drugs which contain precisely the same active ingredients as original trade name at lower monetary value one time the original trade name expires. Therefore, the job of patent termination is capable to competition from generic drugs. As a consequence, the consumer may buy the generic drugs alternatively of original trade name. There is high competition in the market to bring forth the generic drugs since it is demanded by the consumers.

The monetary value of the pharmaceutical merchandises is capable to monetary value control. The monetary value might straight controlled by some authorities. Furthermore, the major buyers of pharmaceutical merchandises are authorities bureaus and private wellness attention suppliers. Therefore, their economic powers are high because they can exert the significant force per unit area on pharmaceutical merchandises monetary value.

Pfizer will work to better their impulse by maximising the value of their in-line portfolio, progressing their grapevine, and go oning maintain high criterions of corporate administration.

For GSK, it aims to cut down its operational H2O ingestion as H2O is of import natural resource. The company intends to play an active function in pull offing it in an efficient mode by mensurating the company ‘s H2O impact across the value concatenation. In add-on, the company is besides intends to heighten its fiscal public presentation for stockholders wealth maximization.

The short-run aim of Novartis is to supply short-run inducement programs that based on outstanding public presentations in the company. For illustration, pension program, wellness screen, and lifestyle benefits.

Pfizer hopes to better planetary wellness by looking for collaborative attack with cardinal stakeholders in work outing of import societal and environmental issue and heightening the value for their stakeholders.

GSK is seeking to cut down the waste to landfill from their operation. Therefore, the company intends to recycle used inhalators and waste plastic and cut down packaging volume in order to accomplish this aim. The company reduced 1.2 % of the waste generated from operation and reduced 25 % of the waste to landfill in 2011. This shows that GSK is traveling toward its long-run aim.

Novartis is expected to bring forth growing benefits from the acquisition of Fougera Pharmamceuticals, a dermatology generics company as Fougera has forte in dermatology development and strong fabrication expertness. It has decided to establish this plan for 2013 and beyond.

Novartis besides expected to organize a community wellness instruction, which concern with the basic disease consciousness by helping the communities to better their wellness and wellbeing.

Pfizer involves in patient-access plans such as Pfizer Helpful Answers-a U.S. enterprise that provides medical specialties for free or at a price reduction to those qualified uninsured and underinsured patients. Besides, they besides involve in nursery gas decrease and H2O preservation.

GSK involves in Personal Hygiene and Sanitation Education ( PHASE ) plan with non-government administrations to learn kids on how to rinse their manus in order to forestall diarrhoea disease as many kids dice of diarrhoea disease. This disease can be prevented by rinsing manus and improving H2O quality.

Novartis has adopted a preventative attack, which encourage doing usage of the natural resources expeditiously in order to cut down the environmental impact of company ‘s merchandises and activities. This attack could do good sense to the concern and reduced the emanations of pollutants.

Grand scheme consists of 4 quarter-circles but merely quadrant III and IV is applicable in our instance.

Market development scheme is recommended to be used by Pfizer as the strategic directors feel that its bing medical specialties would be good received by new clients groups in less developed states. Their trade names are well-received and extremely recognized around the universe because of their quality merchandises. Therefore, people trust their merchandises. Due to this, they are increasing their attempts and resources to prosecute chances in less developed states like Africa. Since their planetary distribution webs are well-established and their planetary fabrication capacity is strong, they can add a distribution centre in Kenya to capture larger market in Africa.

Merchandise development is suggested to be adopted by Pfizer, GSK, and Novartis since they feel that their existing consumers would be interested in medical specialties related to its current lines. There are some bing medical specialties in the market to command bosom disease and Acquired Immune Deficiency Syndrome ( AIDS ) . However, there is still no medical specialties can bring around these diseases. Pfizer, GSK, and Novartis can work together to develop medical specialties by making new medical specialties which is able to bring around the diseases to be marketed to current consumers. They can make the merchandise development by making research and development in this country.

A horizontal integrating is a expansive scheme that based on growing through the acquisition of similar houses runing at the same phase of the production-marketing concatenation. As the universe largest pharmaceutical company, Pfizer is recommended to get new pharmaceutical companies. Such acquisitions could assist to cut down the rivals and supply an easy manner for the geting houses with entree to new markets to spread out their concerns. It is a faster manner, cheaper, and less hazardous for both sides. Pfizer and geting houses can besides derive competitory advantages in the market since there is cut downing of rivals through the acquisitions.

While two companies join together to organize a company, it is called amalgamation. Harmonizing to the failings in SWOT analysis, the Novartis Company had a job of deficiency of resources to seek more attractive chances in the market. It is recommended to unify with another company because it encourages them to unite several resources together. This will increase the market portion monetary value and besides bring forth more net incomes. Then, Novartis will hold more net incomes to finance its hazardous investing in order to offer good quality of merchandises for clients. Furthermore, amalgamation could heighten variegation between two pharmaceutical companies in different industries such as portion of cognition among each others.

While two companies join together to organize a company, it is called amalgamation. Harmonizing to the failings in SWOT analysis, the Novartis Company had a job of deficiency of resources to seek more attractive chances in the market. It is recommended to unify with another company because it encourages them to unite several resources together. This will increase the market portion monetary value and besides bring forth more net incomes. Then, Novartis will hold more net incomes to finance its hazardous investing in order to offer good quality of merchandises for clients. Furthermore, amalgamation could heighten variegation between two pharmaceutical companies in different industries such as portion of cognition among each others.

There are 4 types of strategic control which are premise control, strategic surveillance, particular qui vive control, and execution control. Strategic control is use to track a scheme, observe jobs and do some necessary accommodations in the pharmaceutical industry. Premise control and particular qui vive control are suggested to be used by the direction of pharmaceutical companies.

Pharmaceutical companies can utilize premise control to consistently and continuously look into their current scheme to guarantee their drugs are safety for consumers so that they get trusted. The scheme may hold to be changed if the premiss is no longer valid. Environmental and industry factors will act upon the premiss control. Environmental factors like engineering and ordinance will impact the premiss. All the drugs must be approved by Food and Drug Administration ( FDA ) so that the consumers have assurance about the safety of the drugs. Industry factors like rivals, merchandise replacements, providers, and barriers to entry will impact the public presentation of pharmaceutical companies.

Particular qui vive control is used by the direction to reconsider the pharmaceutical companies ‘ scheme for unexpected events. Pharmaceutical industry should hold some eventuality planning for unexpected disease in the hereafter. It is of import as to guarantee they are able to understate the effects and can cut down the hazard of decease. For illustration, SARS and birds grippe which have high hazard of deceasing.

In decision, the schemes are policies that designed to get the better of the failings and menaces, which shown in our analysis. It brings benefits to the pharmaceutical houses and the consumers. Schemes enable the pharmaceutical houses to be more efficient in run intoing their client demands by supplying high quality merchandises, which could better client satisfactions. High client satisfactions will increase the concern growing rate and heighten the concern repute in the competitory market.

A house should ever carry on marketing research like reappraisal its schemes to guarantee that schemes are keep updating to the current market tendency so that it can prolong in the pharmaceutical industry and acquire competitory advantage. Marketing research could explicate to the houses whether they are carry throughing their clients ‘ outlooks. Another manner is to concentrate on distinction scheme by supplying alone merchandises that are wholly different from what rivals provided to consumers. Differentiation scheme could supply high perceived value and increase market portion for a pharmaceutical house.